参考文献/References:
[1] 王化, 王伟, 唐光健. 肝细胞癌影像学诊断的现状与进展[J]. 中华放射学杂志, 2006, 40 (3):315-318.
[2] Efremidis SC, Hytiroglou P. The multistep process of hepatocarcino-genesis in cirrhosis with imaging correlation[J]. Eur Radiol, 2002, 12 (4):753-764.
[3] Kudo M. Multistep human hepatocarcinogenesis:correlation of imaging with pathology[J]. J Gastroenterol, 2009, 44 Suppl 19:S112-118.
[4] 刘树堂, 齐晓辉, 时高峰, 等. 多种影像学检查技术对小肝癌的综合诊断研究[J]. 河北医药, 2013, 35 (4):526-527.
[5] 许万博, 刘小金. 磁共振动态增强技术在小肝癌诊断中的应用价值[J]. 德州学院学报, 2012, 28 (6):45-47.
[6] Buadu LD, Murakami J, Murayama S, et al. Patterns of peripheral enhancement in breast masses:correlation of findings on contrast medium enhanced MRI with histologic features and tumor angio-genesis[J]. J Comput Assist Tomogr, 1997, 21 (3):421-430.
[7] Wang B, Gao ZQ, Yan X. Correlative study of angiogenesis and dy-namic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma[J]. Acta Radiol, 2005, 46(4):353-358.
[8] 于德新, 马祥兴, 魏华刚, 等. 3.0 T 动态增强 MR 评价肝细胞癌血管生成及其成熟度的价值[J]. 临床放射学杂志, 2009, 28 (3):355-359.
[9] Hsu CY, Shen YC, Yu CW, et al. Dynamic contrast-enhanced mag-netic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil[J]. J Hepatol, 2011, 55 (4):858-865.
[10] Bachmann R, Kreft B, Dombrowski F, et al. Enhanced tumor detec-tion in the presence of liver cirrhosis:experimental study on the diagnostic value of a superparamagnetic iron oxide MR imaging contrast agent (NSR 0430)[J]. J Magn Reson Imaging, 1999, 9(2):251-256.
[11] Paley MR, Mergo PJ, Torres GM, et a1. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imag-ing[J]. AJR Am J Roentgenol, 2000, 175 (1):159-163.
[12] Stadlbauer A, Nimsky C, Gruber S, et al. Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas:a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study[J]. AJNR Am J Neuroradiol, 2007, 28(3):462-469.
[13] Sinba S, Bastin ME, Wardlaw JM, et al. Effects of dexamethasone on peritumoural oedematous brain:a DT-MRI study[J]. J Neurol Neurosurg Psychiatry, 2004, 75 (11):1632-1635.
[14] 张洁, 赵天佐, 赵琴利, 等. 肝硬化相关小肝癌的血供特点和MRI 表现[J]. 中国中西医结合影像学杂志, 2013, 11 (1):1-3, 6.
[15] Bolog N, Andreisek G, Oancea I, et al. CT and MR imaging of hep-atocellular carcinoma[J]. J Gastrointestin Liver Dis, 2011, 20(2):181-189.
[16] Lee NK, Kim S, Lee JW, et al. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications[J]. Radiographics, 2009, 29(6):1707-1724.
[17] Ringe KI, Husarik DB, Sirlin CB, et al. Gadoxetate disodium-enhanced MRI of the liver:part 1, protocol optimization and lesion appearance in the noncirrhotic liver[J]. AJR Am J Roentgenol, 2010, 195 (1):13-28.
[18] Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma:an update[J]. Hepatology, 2011, 53 (3):1020-1022.
[19] Kim HY, Choi JY, Kim CW, et al. Gadolinium ethoxybenzyl di-ethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis[J]. Liver Transpl, 2012, 18 (7):850-857.
[20] Kitao A, Matsui O, Yoneda N, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis:cor-relation with gadoxetic acid enhanced MR imaging[J]. Eur Radiol, 2011, 21 (10):2056-2066.
[21] Motosugi U, Ichikawa T, Sano K, et al. Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease[J]. J Magn Reson Imaging, 2011, 34(1):88-94.
[22] 梁坚豪, 赵继泉, 曾惠良, 等. 磁共振灌注成像对肝硬化增生性结节与小肝癌的鉴别诊断[J]. 临床医学工程, 2012, 19(11):1863-1865.
[23] Rao SX, Chen CZ, Liu H, et al. Three-dimensional whole-liver per-fusion magnetic resonance imaging in patients with hepatocellular carcinomas and colorectal hepatic metastases[J]. BMC Gastroen-terol, 2013, 13:53.
[24] Jin N, Deng J, Chadashvili T, et al. Carbogen gas-challenge BOLD MR imaging in a rat model of diethylnitrosamine-induced liver fibrosis[J]. Radiology, 2010, 254(1):129-137.
[25] Boulanger Y, Amara M, Lepanto L, et al. Diffusion-weighted MR imaging of the liver of hepatitis C patients[J]. NMR Biomed, 2003, 16 (3):132-136.
[26] 黄泽光, 谢长浓, 吴永峻. MR 弥散加权成像诊断肝硬化不典型癌变结节[J]. 中国医学影像技术, 2010, 26:701-703.
[27] 范义. 肝癌化疗栓塞前后 MR 弥散和灌注成像的实验研究[D]. 广州:南方医科大学, 2009.
[28] Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging[J]. J Magn Re-son Imaging, 2005, 22 (4):439-450.
[29] Zhang J, Krinsky GA. Iron-containing nodules of cirrhosis[J]. NMR Biomed, 2004, 17 (7):459-464.
[30] 曾蒙苏, 李若坤. 磁共振磁敏感加权成像在肝硬化结节多步癌变中的临床应用[J]. 临床肝胆病杂志, 2013, 29 (1):38-41.
[31] 张龙江, 祁吉. 肾的血氧水平依赖功能磁共振成像[J]. 中国中西医结合影像学杂志, 2007, 5 (2):42-45.
[32] Robinson SP, Rodrigues LM, Griffiths JR, et al. Response of hep-atoma 9618a and normal liver to host carbogen and carbon monox-ide breathing[J]. Neoplasia, 1999, 1(6):537-543.
[33] Foley LM, Picot P, Thompson RT, et al. In vivo monitoring of hep-atic oxygenation changes in chronically ethanol-treated rats by functional magnetic resonance imaging[J]. Magn Reson Med, 2003, 50 (5):976-983.
[34] Semple SI, Wallis F, Haggarty P, et al. The measurement of fetal liver T2* in utero before and after maternal oxygen breathing:progress towards a non-invasive measurement of fetal oxygenation and placental function[J]. Magn Reson Imaging, 2001, 19(7):921-928.
[35] Neeman M, Dafni H, Bukhari O, et al. In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation:vali-dation by intravital microscopy[J]. Magn Reson Med, 2001, 45(5):887-898.
[36] Orrego H, Blendis LM, Crossley IR, et al. Correlation of intrahepat-ic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat[J]. Gastroenterology, 1981, 80(3):546-556.
[37] Jin N, Deng J, Chadashvili T, et al. Carbogen gas-challenge BOLD MR imaging in a rat model of diethylnitrosamine-induced liver fi-brosis[J]. Radiology, 2010, 254(1):129-137.
[38] Robinson SP, Rodrigues LM, Ojugo AS, et al. The response to car-bogen breathing in experimental tumour models monitored by gra-dient-recalled echo magnetic resonance imaging[J]. Br J Cancer, 1997, 75 (7):1000-1006.
[39] Robinson SP, Rodrigues LM, Griffiths JR, et al. Response of hep-atoma 9618a and normal liver to host carbogen and carbon monox-ide breathing[J]. Neoplasia, 1999, 1(6):537-543.
[40] Rhee TK, Larson AC, Prasad PV, et al. Feasibility of blood oxy-genation level-dependent MR imaging to monitor hepatic tran-scatheter arterial embolization in rabbits[J]. J Vasc Interv Radiol, 2005, 16 (11):1523-1528.
[41] 于德新,马祥兴,魏华刚,等. 利用 R2*、T2* 值无创评估肝细胞癌血氧水平与血管生成及其成熟度的关系[J]. 中国医学科学院学报, 2009, 31 (5):589-593.
相似文献/References:
[1]姚晔,戈伟强,周云,等.BP神经网络模型预测肝肿瘤运动趋势可行性研究[J].国际放射医学核医学杂志,2016,40(1):22.[doi:10.3760/cma.j.issn.1673-4114.2016.01.005]
Yao Ye,Ge Weiqiang,Zhou Yun,et al.Feasibility study on liver tumor motion prediction based on back propagation neural network[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):22.[doi:10.3760/cma.j.issn.1673-4114.2016.01.005]
[2]闵捷,李斌,金凯,等.肝脏磁共振弹性成像的应用现状与展望[J].国际放射医学核医学杂志,2014,38(4):261.[doi:10.3760/cma.j.issn.1673-4114.2014.04.013]
Min Jie,Li Bin,Jin Kai,et al.The application and expectation of magnetic resonance elastography in liver[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):261.[doi:10.3760/cma.j.issn.1673-4114.2014.04.013]
[3]沈秀,刘晓秋,周则卫,等.昆明-无毛小鼠生物学特性的研究[J].国际放射医学核医学杂志,2013,37(2):74.[doi:10.3760/cma.j.issn.1673-4114.2013.02.003]
SHEN Xiu,LIU Xiao-qiu,ZHOU Ze-wei,et al.Biological characteristic of Kunming-hairless mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(3):74.[doi:10.3760/cma.j.issn.1673-4114.2013.02.003]
[4]刘晓秋,王芹,周则卫,等.9401对H22肝癌小鼠放射增敏效应的研究[J].国际放射医学核医学杂志,2013,37(1):13.[doi:10.3760/cma.j.issn.1673-4114.2013.01.004]
LIU Xiao-qiu,WANG Qin,ZHOU Ze-wei,et al.Radiosensitizing effects of 9401 on mice bearing H22 hepatoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(3):13.[doi:10.3760/cma.j.issn.1673-4114.2013.01.004]
[5]王月英,吴红英,李德冠,等.小鼠不同肿瘤模型对放化疗敏感性的研究[J].国际放射医学核医学杂志,2012,36(5):289.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.006]
WANG Yue-ying,WU Hong-ying,LI De-guan,et al.The radiation sensitivities of different mice tumor model to radiotherapy and chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(3):289.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.006]
[6]闫玉军,徐文清,刘晓秋,等.实验肿瘤局部照射动物模型的改进[J].国际放射医学核医学杂志,2013,37(6):337.[doi:10.3760/cma.j.issn.1673-4114.2013.06.003]
YAN Yu-jun,XU Wen-qing,LIU Xiao-qiu,et al.Improvement on the animal model of local irradiation for experimental tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(3):337.[doi:10.3760/cma.j.issn.1673-4114.2013.06.003]
[7]谢燃,李琳,邓智勇,等.18F-FDG耳关合11C-乙酸盐PET-CT在肝癌诊断中的应用[J].国际放射医学核医学杂志,2011,35(3):167.[doi:10.3760/cma.j.issn.1673-4114.2011.03.008]
XIE Ran,LI Lin,DENG Zhi-yong,et al.The applications of 18F-FDG combined with 11C-acetate PET-CT imaging in the diagnosis of hepatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(3):167.[doi:10.3760/cma.j.issn.1673-4114.2011.03.008]
[8]张颖,林军.125I粒子治疗对肝癌细胞凋亡及细胞周期的影响[J].国际放射医学核医学杂志,2009,33(4):193.[doi:10.3760/cma.j.issn.1673-4114.2009.04.001]
ZHANG Ying,LIN Jun.Effects of 125I seed brachytherapy on apoptosis and cell cycle distribution in hepatoma carcinoma cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(3):193.[doi:10.3760/cma.j.issn.1673-4114.2009.04.001]
[9]冯彦林,谭家驹,梁生,等.抗人肝癌188Re-免疫磁性纳米微粒的生物学分布和肿瘤细胞抑制实验[J].国际放射医学核医学杂志,2007,31(6):321.
FENG Yan-lin,TAN Jia-jü,LIANG Sheng,et al.Experimental study of the biological properties of 188Re-Hepama-1 biologic superparamagnetic nanoparticles[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(3):321.
[10]罗作明,吴华.PET代谢显像剂11C-乙酸盐在临床中的应用[J].国际放射医学核医学杂志,2007,31(1):25.
LUO Zuo-ming,WU Hua.Clinical application of 11C-acetate PET metabolism imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(3):25.
[11]冯学民,尹乐,王俊起,等.呋塞米介入及增加核素活度对肝癌和肝硬化患者骨显像的改善[J].国际放射医学核医学杂志,2008,32(2):79.
FENG Xue-min,YIN Le,WANG Jun-qi,et al.The influence of bone scintigraphy in hepatic carcinoma and hepatocirrhosis with furosemide interventional test and increase radioactivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(3):79.